These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6432417)

  • 21. Comparison of oral and parenteral gold therapy and placebo in the treatment of rheumatoid arthritis.
    Williams HJ; Ward JR
    Scand J Rheumatol Suppl; 1983; 51():92-9. PubMed ID: 6426054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auranofin in the treatment of rheumatoid arthritis. A two-year study.
    Baldassare AR; Weiss TD; Arthur RE; Osborn TG; Moore TL; Zuckner J
    Mo Med; 1985 Nov; 82(11):711-5. PubMed ID: 3934512
    [No Abstract]   [Full Text] [Related]  

  • 23. Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.
    Williams HJ; Ward JR; Egger MJ; Reading JC; Samuelson CO; Altz-Smith M; Willkens RW; Solsky MA; Hayes SP; Furst D
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():39-50. PubMed ID: 6432412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis.
    Larsen A; Horton J; Howland C
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():97-104. PubMed ID: 6432419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug treatment of rheumatoid arthritis.
    Huskisson EC
    Int Rehabil Med; 1984; 6(1):i-ii. PubMed ID: 6429077
    [No Abstract]   [Full Text] [Related]  

  • 26. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 28. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.
    van Riel PL; Gribnau FW; van de Putte LB
    J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Auranofin in the treatment of juvenile rheumatoid arthritis.
    Giannini EH; Brewer EJ; Person DA
    J Pediatr; 1983 Jan; 102(1):138-41. PubMed ID: 6401327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interim results of a multicenter open study with auranofin in Japan.
    Homma M; Abe T; Akizuki M; Shiokawa Y; Shichikawa K; Kageyama T; Yoshizawa H; Azuma T; Mizushima Y; Okazaki T; Sugawara S
    J Rheumatol Suppl; 1982; 8():160-8. PubMed ID: 6813479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E
    Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoporosis in the rheumatoid hand--the effects of treatment with D-penicillamine and oral gold salts.
    Schorn D
    S Afr Med J; 1983 Jan; 63(4):121-3. PubMed ID: 6401365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of correlation between blood gold concentrations and clinical response in patients with definite or classic rheumatoid arthritis receiving auranofin or gold sodium thiomalate.
    Dahl SL; Coleman ML; Williams HJ; Altz-Smith M; Kay DR; Paulus HE; Weinstein A; Kaplan S
    Arthritis Rheum; 1985 Nov; 28(11):1211-8. PubMed ID: 3933523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An oral gold formulation in rheumatoid arthritis. A 12-month follow-up report.
    Schorn D
    S Afr Med J; 1982 Aug; 62(10):313-6. PubMed ID: 6810477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial experience with oral gold salts in the treatment of rheumatoid arthritis in patients followed up for one year.
    Lignère GC; Giavarini S; Longatti S
    J Int Med Res; 1984; 12(3):193-7. PubMed ID: 6428946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes of immunological parameters during auranofin treatment in children affected with juvenile chronic arthritis.
    Fantini F; Cottafava F; Martini A; Murelli M; Franchini E; D'Errico R; Panzarasa R
    Int J Clin Pharmacol Res; 1986; 6(1):61-7. PubMed ID: 3082775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auranofin in juvenile rheumatoid arthritis. An open label, non-controlled study.
    Garcia-Morteo O; Suarez-Almazor ME; Maldonado-Cocco JA; Cuttica R; Abate S
    Clin Rheumatol; 1984 Jun; 3(2):223-7. PubMed ID: 6432407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.